← Back to Search

Probiotic

1 for MRSA Colonization (MRSA Trial)

Phase 2
Waitlist Available
Led By Dr Pierre-Jean PM Maziade, MD
Research Sponsored by Bio-K Plus International Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

Trial Objectives: Primary objective: * To evaluate the efficacy of Bio-K+CL1285® in patients with Methicillin-Resistant S. aureus (MRSA) nasal colonization by comparing the MRSA decolonization following either Bio-K+CL1285® or placebo treatment. Secondary objective: * To evaluate the safety profile of Bio-K+CL1285®.

Eligible Conditions
  • MRSA Colonization

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1Experimental Treatment1 Intervention
Bio-K+ CL1285 contains 50 billion of live bacteria
Group II: 2Placebo Group1 Intervention
placebo devoid of bacteria

Find a Location

Who is running the clinical trial?

Bio-K Plus International Inc.Lead Sponsor
7 Previous Clinical Trials
1,451 Total Patients Enrolled
Centre Hospitalier Pierre-Le GardeurUNKNOWN
Dr Pierre-Jean PM Maziade, MDPrincipal InvestigatorPierre Le Gardeur Hospital
~0 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top